Business and Finance

Alliance with Jointown comes in time for Covid-19 vaccine storage and distribution efforts

Joins UK consortium to help efficiently manufacture oral solid dosage medication

Deals provide Andlauer Healthcare Group full Skeleton Canada ownership and 49 percent stake in US branch

Supply chain management and logistics company boosts its US presence

Company says it will be able to produce an estimated 12 million doses per month

Pair of agreements expands packaging company's international network

Acquisition is 3PL provider's largest one yet

Acquisition grows Antares’ track-and-trace presence

Strengthens the CRO's scientific capabilities in cell and gene therapy space

Lab development project features 9,000-square-foot expansion

Combine their expertise in immunology and infectious diseases to speed up development of mAbs for influenza

Acquires Scientific Commercialization, a medical affairs consulting and analytics business

PBM's own specialty pharmacy unit adds CareMetx Health, growing its coverage base to the eastern US

Deal will help expand its pharma presence

Becomes a partner in UK consortium focused on enabling new and disruptive manufacturing technologies

UK cell and gene therapy location expected to be cGMP-ready by mid-2022

Will help biomed startups in furthering oncology R&D

There are currently 100,000 doses standing by

$180M collaboration aims to introduce multiple vaccine candidates in 2022

Two-dose COVAXIN currently under EUA in India

CDMO to take over operations, including equipment and workforce, at site in Couvet, Switzerland

Deal completes Verista's lifecycle support for pharma, which now includes consulting, technology and manufacturing

Agreement provides Acentrus with specialty pharmacy accreditation

In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility

Production expected to begin in the second quarter